Weiterführende Informationen zu den einzelnen klinischen Studien finden sich hier:

ClinicalTrials.gov. (2021, 14. Juli). Dose Escalation Study of AST-OPC1 in Spinal Cord Injury. https://clinicaltrials.gov/study/NCT02302157

Asterias Biotherapeutics. Scistar Study. https://www.scistar-study.com/ 

California Institute for Regenerative Medicine (CIRM). (o. D.). Grant Award Details. A Phase I/IIa Dose Escalation Safety Study of AST-OPC1 in Patients with Cervical Sensorimotor Complete Spinal Cord Injury. Zugriff am 30. Januar 2025 von https://www.cirm.ca.gov/grants/